FDA 483 - InvaTech Pharma Solutions, LLC - April 04, 2017

InvaTech Pharma Solutions, LLC in East Brunswick, New Jersey, was cited with four observations during an FDA inspection. The observations primarily concern deficiencies in laboratory controls, production and process controls, and record-keeping related to drug product manufacturing. These issues indicate significant problems with quality assurance and data integrity at the facility.